Authors: SOBRERO A ASCHELE C GUGLIELMI A MORI A TIXI L BOLLI E GROSSI F

Citation: A. Sobrero et al., CIRCUMVENTION OF RESISTANCE TO 5-FLUOROURACIL BY SCHEDULE-ORIENTED BIOCHEMICAL MODULATION IN ADVANCED COLON-CANCER PATIENTS, European journal of cancer, 31A, 1995, pp. 305-305

Authors: ASCHELE C GUGLIELMI A MORI A TIXI L BOLLI E CIFERRI E FAZIO S MUNICINO O SOBRERO A

Citation: C. Aschele et al., THE 2 SIDES OF 5-FLUOROURACIL - BOLUS AND CONTINUOUS-INFUSION, Journal of experimental & clinical cancer research, 14(2), 1995, pp. 53-59

Authors: BOLLI E SACCOMANNO S MONDINI G ASCHELE C GUGLIELMI A LIGAS B CONNIO M MORI A ROSSO R SOBRERO A TIXI L PUGLIESE V

Citation: E. Bolli et al., 5-FLUOROURACIL PLUS 5-METHYLTETRAHYDROFOLATE IN ADVANCED PANCREATIC-CANCER, Cancer chemotherapy and pharmacology, 35(4), 1995, pp. 339-342

Authors: ROSSO R MAZZEI T SOBRERO A MINI E CARTEI G CONTE P LABIANCA R CARTEI F FALCONE A PANCERA G BARSANTI G DICOSTANZO F GUGLIELMI A BOLLI E TIXI L ASCHELE C RIBECCO A PERITI P

Citation: R. Rosso et al., PHASE-II TRIAL OF 5-FLUOROURACIL AND THE NATURAL 1-ISOMER OF FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL-CARCINOMA, European journal of cancer, 30A(3), 1994, pp. 338-343

Authors: MORI A BERTOGLIO S GUGLIELMI A ASCHELE C BOLLI E TIXI L ROSSO R SOBRERO A

Citation: A. Mori et al., ACTIVITY OF CONTINUOUS-INFUSION 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER CLINICALLY RESISTANT TO BOLUS 5-FLUOROURACIL, Cancer chemotherapy and pharmacology, 33(2), 1993, pp. 179-180